Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525

Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
Warning: file_get_contents(http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=19458798&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 445
  English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |   
lüll Restless legs syndrome Yee B; Killick R; Wong KAust Fam Physician 2009[May]; 38 (5): 296-300BACKGROUND: Restless legs syndrome (RLS) is a common, but frequently undiagnosed, chronic, sensorimotor disorder. In western countries, it is seen in approximately 10% of the general population, with a higher prevalence in women and the elderly (10-20%). OBJECTIVE: This article outlines the epidemiology, aetiology, diagnosis and management of RLS. Information that is most relevant to general practice is presented, with an emphasis on practical management. DISCUSSION: Restless legs syndrome is divided into primary and secondary forms. There is a strong genetic influence in primary RLS. Secondary forms are associated with iron deficiency, pregnancy, and renal failure. Diagnosis is essentially by clinical history using simple diagnostic criteria. Management depends on severity, and ranges from nonpharmacologic to pharmacologic measures. Recent research has provided insights into the pathophysiology of RLS and provided an evidence base for some of the newer treatments.|Algorithms[MESH]|Amines/therapeutic use[MESH]|Analgesics, Opioid/therapeutic use[MESH]|Benzodiazepines/therapeutic use[MESH]|Carbidopa/therapeutic use[MESH]|Causality[MESH]|Cyclohexanecarboxylic Acids/therapeutic use[MESH]|Dopamine Agents/therapeutic use[MESH]|Excitatory Amino Acid Antagonists/therapeutic use[MESH]|Female[MESH]|Gabapentin[MESH]|Humans[MESH]|Hypnotics and Sedatives/therapeutic use[MESH]|Levodopa/therapeutic use[MESH]|Middle Aged[MESH]|Oxycodone/therapeutic use[MESH]|Practice Guidelines as Topic[MESH]|Restless Legs Syndrome/*diagnosis/epidemiology/*therapy[MESH]|Treatment Outcome[MESH]|gamma-Aminobutyric Acid/therapeutic use[MESH] |